15 July 2023. Investments in life science start-ups in the U.S. show continued declines into the second quarter of 2023, reaching levels not seen in four or five years. The investment market research company Pitchbook and National Venture Capital Association released the data this week in their quarterly venture monitor report.
The Pitchbook/NVCA data show life science entrepreneurs raising $7 billion in 421 deals from April through June 2023. While the $7 billion dollar raised is about the same as the $7.2 billion in the first quarter, those investment volumes are lower than any quarterly totals since 2019. And the 421 venture transactions are the lowest quarterly totals since mid-2018. For 2023 as a whole, life science start-ups in the U.S. so far raised $14.2 billion in 903 deals.
Venture investors this year are making fewer angel/seed and early-stage life science deals this year than last year. Angel, seed, and early-stage deals in the first half of 2023 account for a little more than half (52%) of all deals, compared to nearly six in 10 life science deals (59%) for all of 2022. For venture investing overall in the U.S., quarterly deal counts are generally stable since the second half of 2022, but investment dollar volumes have dropped steadily since 2021.
More from Science & Enterprise:
- Venture Fund to Back Life Science A.I. Start-Ups
- Infographic – Venture Funds Continue Slide in Q2
- Infographic – Climate Start-Ups Still Gaining Venture Funds
We designed Science & Enterprise for busy readers including investors, researchers, entrepreneurs, and students. Except for a narrow cookies and privacy strip for first-time visitors, we have no pop-ups blocking the entire page, nor distracting animated GIF graphics. If you want to subscribe for daily email alerts, you can do that here, or find the link in the upper left-hand corner of the desktop page. The site is free, with no paywall. But, of course, donations are gratefully accepted.
[wpedon id=”42724″ align=”center”]
* * *
You must be logged in to post a comment.